P1231: ZILOVERTAMAB VEDOTIN (MK‐2140) FOR THE TREATMENT OF NON‐HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE‐001 STUDY OF AN ANTI‐ROR1 ANTIBODY‐DRUG CONJUGATE

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 6; no. Suppl; pp. 1116 - 1117
Main Authors Wang, M., Mei, M., Barr, P. M., Barrientos, J., Vos, S., Furman, R., Patel, K., Thompson, P. A., Choi, M., Kallam, A., Zhu, Y., Chakraborty, S., Marinello, P., Spurgeon, S. E.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 23.06.2022
Wiley
Online AccessGet full text

Cover

More Information
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000847788.96420.63